Profile data is unavailable for this security.
About the company
CVS Health Corporation is a health solutions company. The Company operates in four segments: Health Care Benefits, Health Services, Pharmacy & Consumer Wellness, and Corporate/Other. Its Health Care Benefits segment offer a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare supplement plans, and Medicaid health care management services. Its Health Services segment provides a full range of pharmacy benefit management solutions, delivers health care services in its medical clinics, virtually, and in the home, and offers provider enablement solutions. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations, provides ancillary pharmacy services, including pharmacy patient care programs, diagnostic testing and vaccination administration.
- Revenue in USD (TTM)368.91bn
- Net income in USD5.02bn
- Incorporated1996
- Employees300.00k
- LocationCVS Health Corp1 Cvs DrWOONSOCKET 02895-6146United StatesUSA
- Phone+1 (401) 765-1500
- Fax+1 (302) 655-5049
- Websitehttps://cvshealth.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tenet Healthcare Corp | 20.97bn | 3.13bn | 14.44bn | 78.14k | 4.86 | 3.77 | 3.02 | 0.6885 | 31.26 | 31.26 | 209.81 | 40.32 | 0.7364 | 9.49 | 7.15 | 268,376.30 | 13.86 | 3.61 | 20.23 | 5.09 | 82.61 | 82.97 | 18.83 | 4.95 | 1.52 | 5.37 | 0.6145 | 0.00 | 7.17 | 2.33 | 49.02 | 41.42 | 4.01 | -- |
| Molina Healthcare Inc | 39.20bn | 1.14bn | 16.85bn | 18.00k | 14.95 | 3.52 | 12.72 | 0.4299 | 19.70 | 19.70 | 674.97 | 83.68 | 2.56 | -- | 13.71 | 2,177,722.00 | 7.47 | 7.62 | 16.58 | 16.80 | 16.12 | 15.99 | 2.92 | 3.04 | -- | 14.83 | 0.3465 | 0.00 | 6.56 | 12.52 | 37.75 | 9.06 | 22.87 | -- |
| Quest Diagnostics Inc | 9.54bn | 838.00m | 18.01bn | 40.00k | 21.66 | 2.65 | 13.49 | 1.89 | 7.45 | 7.45 | 84.79 | 60.79 | 0.645 | 34.77 | 7.18 | 238,475.00 | 5.87 | 9.28 | 6.77 | 10.81 | 32.94 | 36.64 | 9.10 | 12.97 | 1.17 | 8.87 | 0.4746 | 25.07 | -6.38 | 4.20 | -9.77 | 3.40 | 1.27 | 7.43 |
| Labcorp Holdings Inc | 12.71bn | 435.50m | 19.89bn | 67.00k | 46.09 | 2.44 | 18.84 | 1.56 | 5.16 | 5.16 | 150.40 | 97.61 | 0.7162 | 19.41 | 5.93 | 189,743.30 | 2.46 | 6.27 | 3.00 | 7.37 | 27.92 | 32.33 | 3.44 | 9.51 | 1.30 | 5.59 | 0.455 | -- | 2.51 | 1.42 | -62.16 | -16.40 | 3.62 | -- |
| Natera Inc | 1.53bn | -214.69m | 20.76bn | 3.28k | -- | 23.72 | -- | 13.55 | -1.77 | -1.77 | 12.59 | 7.08 | 1.01 | 14.29 | 5.45 | 466,774.80 | -14.14 | -36.17 | -17.55 | -46.60 | 57.66 | 45.88 | -14.01 | -56.15 | 4.23 | -- | 0.2947 | -- | 31.99 | 33.26 | 20.63 | -- | 58.81 | -- |
| Centene Corp | 161.73bn | 3.07bn | 29.84bn | 67.70k | 10.25 | 1.10 | 6.95 | 0.1845 | 5.77 | 5.77 | 303.72 | 53.53 | 1.94 | -- | 9.57 | 2,388,863.00 | 3.66 | 2.58 | 6.39 | 3.99 | 10.37 | 11.59 | 1.89 | 1.37 | -- | 4.06 | 0.3911 | 0.00 | 6.54 | 20.70 | 124.79 | 24.59 | 3.43 | -- |
| Humana Inc | 115.01bn | 1.36bn | 35.40bn | 67.60k | 26.03 | 2.02 | 14.72 | 0.3078 | 11.29 | 11.29 | 948.23 | 145.88 | 2.17 | -- | -- | 1,701,331.00 | 2.72 | 7.57 | -- | -- | -- | -- | 1.25 | 3.35 | -- | 5.38 | 0.4249 | 12.54 | 14.54 | 13.33 | -11.30 | 7.65 | 10.41 | 13.25 |
| CVS Health Corp | 368.91bn | 5.02bn | 71.52bn | 300.00k | 14.44 | 0.9539 | 7.45 | 0.1939 | 3.94 | 3.94 | 290.60 | 59.57 | 1.46 | 17.78 | 36.33 | 1,229,707.00 | 1.99 | 3.03 | 2.97 | 4.20 | 14.20 | 17.07 | 1.36 | 2.30 | 0.5872 | 3.88 | 0.466 | 40.46 | 10.95 | 12.95 | 93.55 | -- | 8.27 | 3.89 |
| HCA Healthcare Inc | 69.62bn | 5.93bn | 84.35bn | 220.00k | 14.94 | -- | 8.37 | 1.21 | 22.28 | 22.28 | 261.95 | -8.57 | 1.22 | 5.54 | 7.29 | 316,459.10 | 11.98 | 11.99 | 16.88 | 15.75 | 84.85 | 84.10 | 9.81 | 10.17 | 0.9991 | 5.30 | 0.982 | 10.54 | 7.86 | 6.84 | -7.11 | 10.13 | 5.83 | 11.38 |
| Cigna Group | 232.59bn | 3.04bn | 89.95bn | 72.50k | 30.50 | 2.15 | 14.41 | 0.3868 | 10.60 | 10.60 | 811.50 | 150.61 | 1.51 | 43.48 | 9.91 | 3,208,083.00 | 2.18 | 4.09 | 3.30 | 5.55 | 11.21 | 13.98 | 1.44 | 3.61 | 0.7736 | 2.33 | 0.4368 | 13.69 | 8.17 | 32.15 | -22.97 | 14.42 | 24.40 | 161.81 |
| Elevance Health Inc | 174.02bn | 6.42bn | 92.18bn | 104.90k | 14.49 | 2.11 | 11.81 | 0.5298 | 27.44 | 27.44 | 743.42 | 188.74 | 1.53 | -- | -- | 1,658,866.00 | 5.63 | 6.03 | -- | -- | -- | -- | 3.67 | 3.96 | -- | 8.36 | 0.3822 | 20.18 | 9.42 | 13.21 | 1.58 | 9.97 | 1.42 | 14.56 |
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 30 Sep 2024 | 111.69m | 8.88% |
| Dodge & Coxas of 30 Sep 2024 | 63.03m | 5.01% |
| BlackRock Fund Advisorsas of 30 Sep 2024 | 59.76m | 4.75% |
| SSgA Funds Management, Inc.as of 30 Sep 2024 | 56.53m | 4.49% |
| Capital Research & Management Co. (World Investors)as of 30 Sep 2024 | 48.22m | 3.83% |
| Geode Capital Management LLCas of 30 Sep 2024 | 26.36m | 2.10% |
| Capital Research & Management Co. (International Investors)as of 30 Sep 2024 | 25.45m | 2.02% |
| Fidelity Management & Research Co. LLCas of 30 Sep 2024 | 15.98m | 1.27% |
| Norges Bank Investment Managementas of 30 Jun 2024 | 14.90m | 1.19% |
| Pzena Investment Management LLCas of 30 Sep 2024 | 13.14m | 1.04% |
